CV Sciences, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|
| Revenue | $20.7M | $11.1M | $11.5M | $10.2M | $2.2M | $0 |
| Cost of Revenue | $6.2M | $4.1M | $4.8M | $4.4M | $880.5K | $0 |
| Gross Profit | $14.5M | $7.0M | $6.7M | $5.8M | $1.3M | $0 |
| Gross Margin | 70.1% | 63.3% | 58.4% | 57.0% | 59.1% | — |
| Operating Expenses | ||||||
| Research & Development | $724.0K | $1.2M | $1.3M | $999.3K | $524.5K | $0 |
| SG&A Expense | $16.2M | $13.1M | $17.4M | $13.4M | $2.4M | $43.0K |
| Operating Income | $-4.9M | $-13.1M | $-11.2M | $-8.6M | $-1.6M | $-43.0K |
| Operating Margin | -23.5% | -118.2% | -97.2% | -83.9% | -75.1% | — |
| Interest Expense | $507.0K | $1.1M | $968.6K | $615.3K | $372.1K | $2.6K |
| Pretax Income | $-5.4M | $-14.1M | $-12.2M | — | — | — |
| Income Tax Expense | $-482.0K | $0 | $0 | $0 | $0 | $0 |
| Net Income | $-4.9M | $-14.1M | $-12.2M | $-1.3M | $-2.3M | $-45.6K |
| Net Margin | -23.7% | -127.9% | -106.1% | -12.9% | -106.8% | — |
| EPS (Basic) | $-0.06 | $-0.27 | $-0.35 | $-0.04 | $-0.08 | $0.00 |
| EPS (Diluted) | $-0.06 | $-0.27 | $-0.35 | — | $-0.08 | $0.00 |
| Shares Outstanding (Basic) | 80.4M | 57.6M | 35.1M | 31.6M | 29.6M | 21.0M |
| Shares Outstanding (Diluted) | 80.4M | 57.6M | 35.1M | 31.6M | 29.6M | 21.0M |
| Dividends Per Share | — | — | — | — | — | — |